See more : Athene Holding Ltd. (ATH-PA) Income Statement Analysis – Financial Results
Complete financial analysis of Cardiff Lexington Corporation (CDIX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cardiff Lexington Corporation, a leading company in the Asset Management industry within the Financial Services sector.
- Konya Çimento Sanayii Anonim Sirketi (KONYA.IS) Income Statement Analysis – Financial Results
- Yunnan Copper Co., Ltd. (000878.SZ) Income Statement Analysis – Financial Results
- Aquaron Acquisition Corp. (AQU) Income Statement Analysis – Financial Results
- Mountain Crest Acquisition Corp. IV (MCAF) Income Statement Analysis – Financial Results
- SaverOne 2014 Ltd (SAVR.TA) Income Statement Analysis – Financial Results
Cardiff Lexington Corporation (CDIX)
About Cardiff Lexington Corporation
Cardiff Lexington Corporation, together with its subsidiaries, provides affordable housing and tax resolution services in the United States. It also leases and sells mobile homes and mobile home parks, as well as offers an alternative to traditional housing. The company provides tax resolution bookkeeping, and tax preparation service to individuals and companies that have federal and state tax liabilities. It also engages in the commercial real estate property business. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation was incorporated in 2001 and is headquartered in Fort Lauderdale, Florida.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 11.85M | 12.00M | 10.01M | 3.45M | 4.54M | 2.37M | 1.74M | 1.15M | 1.39M | 890.40K | 0.00 | 839.00 | 262.00 | 585.00 | 183.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 3.56M | 4.46M | 3.85M | 1.67M | 2.30M | 1.63M | 1.36M | 797.07K | 997.73K | 653.87K | 0.00 | 800.99K | 0.00 | 0.00 | 0.00 | 224.41K | 0.00 | 0.00 | 579.20K | 0.00 | 0.00 |
Gross Profit | 8.29M | 7.54M | 6.16M | 1.78M | 2.24M | 746.24K | 388.25K | 353.18K | 391.87K | 236.53K | 0.00 | -800.15K | 262.00 | 585.00 | 183.00 | -224.41K | 0.00 | 0.00 | -579.20K | 0.00 | 0.00 |
Gross Profit Ratio | 69.96% | 62.85% | 61.55% | 51.69% | 49.42% | 31.43% | 22.25% | 30.70% | 28.20% | 26.56% | 0.00% | -95,369.96% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 3.08M | 2.70M | 4.43M | 3.59M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 593.86K | 686.57K | 713.21K | 1.53M | 0.00 | 0.00 | 1.37M | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 1.03M | 85.87K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.93K | 14.45K | 21.16K | 180.00K | 0.00 | 0.00 | 200.00K | 0.00 | 0.00 |
SG&A | 3.08M | 3.73M | 4.52M | 3.59M | 3.55M | 3.27M | 2.05M | 2.34M | 4.30M | 12.69M | 11.04M | 0.00 | 614.79K | 701.01K | 734.37K | 1.71M | 690.98K | 1.22M | 1.57M | 5.13K | 5.12K |
Other Expenses | 20.78K | 23.13K | 13.89K | 1.27K | 7.32K | 1.74K | 246.33K | 2.51M | 4.30M | 12.69M | 2.91M | 820.07K | 474.55K | 718.26K | 162.51K | 176.02K | 0.00 | 0.00 | 790.55K | 0.00 | 0.00 |
Operating Expenses | 3.08M | 3.76M | 4.53M | 3.59M | 3.56M | 3.29M | 2.30M | 2.51M | 4.30M | 12.69M | 2.91M | 820.07K | 1.09M | 1.42M | 896.88K | 1.88M | 690.98K | 1.22M | 1.57M | 5.13K | 5.12K |
Cost & Expenses | 6.66M | 8.21M | 8.38M | 5.26M | 5.86M | 4.92M | 3.65M | 3.31M | 5.30M | 13.34M | 2.91M | 820.07K | 1.09M | 1.42M | 896.88K | 1.88M | 690.98K | 1.22M | 1.57M | 5.13K | 5.12K |
Interest Income | 0.00 | 6.65M | 2.96M | 1.52M | 1.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.09M | 6.65M | 4.03M | 1.52M | 1.46M | 1.31M | 708.38K | 48.79K | 32.10K | 61.11K | 505.59K | 521.40K | 906.57K | 329.27K | 264.59K | 228.49K | 97.62K | 93.03K | 147.57K | 0.00 | 1.72K |
Depreciation & Amortization | 20.78K | 23.13K | 13.89K | 23.10K | 278.15K | 79.30K | 227.96K | 174.86K | 84.75K | 39.99K | 155.00 | 15.75K | 11.57K | 1.09K | 122.01K | 100.70K | 13.02K | 37.52K | 42.50K | 0.00 | 0.00 |
EBITDA | 5.23M | 3.93M | 1.68M | -1.37M | -4.84M | -2.59M | -2.74M | -1.99M | -3.83M | -13.03M | -11.04M | 1.13M | -1.92M | -1.96M | -870.57K | -1.67M | -677.96K | -1.22M | -1.58M | -5.13K | -5.12K |
EBITDA Ratio | 44.11% | 32.98% | 18.63% | -51.58% | -27.49% | -103.73% | -94.09% | -172.55% | -275.30% | -1,394.07% | 0.00% | -95,766.15% | -411,261.07% | -242,325.30% | -438,820.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | 5.20M | 3.93M | 1.83M | -1.80M | -1.32M | -4.30M | -2.84M | -2.16M | -3.91M | -12.45M | -2.91M | -819.23K | -1.09M | -1.42M | -896.70K | -1.88M | -690.98K | -1.22M | -1.57M | -5.13K | -5.12K |
Operating Income Ratio | 43.83% | 32.79% | 18.28% | -52.25% | -28.98% | -181.30% | -162.91% | -187.75% | -281.40% | -1,398.56% | 0.00% | -97,643.62% | -415,680.15% | -242,511.62% | -489,998.91% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -2.08M | -7.16M | -1.97M | -1.12M | -5.31M | -1.93M | -809.77K | -94.88K | -34.05K | -678.92K | -8.07M | 1.42M | -1.75M | -870.65K | -238.59K | 216.06K | -97.62K | -56.07K | -98.76K | 0.00 | 0.00 |
Income Before Tax | 3.11M | -5.47M | -1.43M | -2.97M | -6.07M | -6.27M | -5.00M | -2.25M | -3.94M | -13.13M | -10.98M | 596.25K | -2.83M | -2.29M | -868.35K | -1.67M | -788.60K | -1.28M | -1.67M | 0.00 | 0.00 |
Income Before Tax Ratio | 26.28% | -45.59% | -14.28% | -86.14% | -133.73% | -263.92% | -286.61% | -196.00% | -283.85% | -1,474.81% | 0.00% | 71,066.15% | -1,081,988.93% | -391,340.17% | -474,506.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 2.72M | 3.22M | 1.46M | 1.75M | 2.41M | 2.38M | 46.09K | 1.95K | 617.81K | 7.57M | -1.94M | 839.17K | 541.38K | -54.35K | -432.13K | 97.62K | -73.92K | -97.62K | 2.32K | 6.84K |
Net Income | 3.03M | -8.19M | -4.65M | -4.43M | -7.82M | -6.27M | -5.00M | -2.25M | -3.94M | -13.13M | -10.98M | 596.25K | -2.83M | -2.29M | -1.14M | -1.90M | -788.60K | -1.28M | -1.67M | -7.45K | -6.84K |
Net Income Ratio | 25.55% | -68.24% | -46.43% | -128.29% | -172.31% | -263.92% | -286.61% | -196.00% | -283.85% | -1,474.81% | 0.00% | 71,066.15% | -1,081,988.93% | -391,340.17% | -620,373.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 151.77 | -818.82 | -2.72K | -63.28K | -23.11M | -104.42K | -1.25M | -2.25M | -773.72 | -4.00K | 471.14M | 260.68K | -2.83M | -2.29M | -1.14M | -1.90M | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
EPS Diluted | 146.14 | -818.82 | -2.72K | -63.28K | -23.11M | -104.42K | -1.25M | -2.25M | -773.72 | -4.00K | 471.14M | 260.68K | -2.83M | -2.29M | -1.14M | -1.90M | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 |
Weighted Avg Shares Out | 14.81K | 10.00M | 1.71M | 70.00K | 0.34 | 60.00 | 4.00 | 1.00 | 5.10K | 3.29K | 0.00 | 3.00 | 1.00 | 1.00 | 1.00 | 1.00 | 166.13M | 166.13M | 166.13M | 166.13M | 166.13M |
Weighted Avg Shares Out (Dil) | 15.39K | 10.00M | 1.71M | 70.00K | 0.34 | 60.00 | 4.00 | 1.00 | 5.10K | 3.29K | 0.00 | 3.00 | 1.00 | 1.00 | 1.00 | 1.00 | 166.13M | 166.13M | 166.13M | 166.13M | 166.13M |
Cardiff Lexington Announces Third Quarter 2024 Financial Results
Cardiff Lexington Announces Second Quarter 2024 Financial Results
Cardiff Lexington Opens 12th Nova Ortho and Spine Location in Orlando, Florida
Cardiff Lexington Announces Elimination of Convertible Debt
Cardiff Lexington Announces Addition of Controller and Staff Accountant to Enhance Finance Team and Support Anticipated Growth
Cardiff Lexington Announces First Quarter 2024 Financial Results
Cardiff Lexington Announces Fourth Quarter and Full Year 2023 Financial Results
Cardiff Lexington Opens Eleventh Nova Ortho and Spine Location in Valdosta, Georgia
Cardiff Lexington Appoints Dr. Kevin Fitzgerald, M.D. as Managing Director of Nova Ortho and Spine
Cardiff Lexington Announces Reverse Stock Split As Part of Ongoing Strategy To Uplist To Major U.S. Exchange
Source: https://incomestatements.info
Category: Stock Reports